Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1643-15-8

Post Buying Request

1643-15-8 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1643-15-8 Usage

Chemical Properties

Slightly beige crystalline powder

Check Digit Verification of cas no

The CAS Registry Mumber 1643-15-8 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 1,6,4 and 3 respectively; the second part has 2 digits, 1 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 1643-15:
(6*1)+(5*6)+(4*4)+(3*3)+(2*1)+(1*5)=68
68 % 10 = 8
So 1643-15-8 is a valid CAS Registry Number.
InChI:InChI=1/C9H10O3/c1-7-3-2-4-8(5-7)12-6-9(10)11/h2-5H,6H2,1H3,(H,10,11)/p-1

1643-15-8 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Alfa Aesar

  • (B24869)  3-Methylphenoxyacetic acid, 98%   

  • 1643-15-8

  • 5g

  • 509.0CNY

  • Detail
  • Alfa Aesar

  • (B24869)  3-Methylphenoxyacetic acid, 98%   

  • 1643-15-8

  • 25g

  • 2322.0CNY

  • Detail
  • Alfa Aesar

  • (B24869)  3-Methylphenoxyacetic acid, 98%   

  • 1643-15-8

  • 100g

  • 7057.0CNY

  • Detail

1643-15-8SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name 2-(3-methylphenoxy)acetic acid

1.2 Other means of identification

Product number -
Other names Acetic acid, (3-methylphenoxy)-

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:1643-15-8 SDS

1643-15-8Relevant articles and documents

Potential anticancer agents--L. Non-classical antimetabolites. II. Some factors in the design of exoalkylating enzyme inhibitors, particulary of lactic dehydrogenase.

BAKER,LEE,SKINNER,MARTINEZ,TONG

, p. 633 - 657 (1960)

-

Ketoreductase catalyzed stereoselective bioreduction of α-nitro ketones

Wang, Zexu,Wu, Xiaofan,Li, Zhining,Huang, Zedu,Chen, Fener

supporting information, p. 3575 - 3580 (2019/04/14)

We report here the stereoselective bioreduction of α-nitro ketones catalyzed by ketoreductases (KREDs) with publicly known sequences. YGL039w and RasADH/SyADH were able to reduce 23 class I substrates (1-aryl-2-nitro-1-ethanone (1)) and ten class II substrates (1-aryloxy-3-nitro-2-propanone (4)) to furnish both enantiomers of the corresponding β-nitro alcohols, with good-to-excellent conversions (up to >99%) and enantioselectivities (up to >99% ee) being achieved in most cases. To the best of our knowledge, KRED-mediated reduction of class II α-nitro ketones (1-aryloxy-3-nitro-2-propanone (4)) is unprecedented. Select β-nitro alcohols, including the synthetic intermediates of bioactive molecules (R)-tembamide, (S)-tembamide, (S)-moprolol, (S)-toliprolol and (S)-propanolol, were stereoselectively synthesized in preparative scale with 42% to 90% isolated yields, showcasing the practical potential of our developed system in organic synthesis. Finally, the advantage of using KREDs with known sequence was demonstrated by whole-cell catalysis, in which β-nitro alcohol (R)-2k, the key synthetic intermediate of hypoglycemic natural product (R)-tembamide, was produced in a space-time yield of 178 g L?1 d?1 as well as 95% ee by employing the whole cells of a recombinant E. coli strain coexpressing RasADH and glucose dehydrogenase as the biocatalyst.

Isoflavone amide derivatives, their preparation method and medical use

-

Paragraph 0077, (2017/08/31)

The invention belongs to the field of medicinal chemistry, and relates to derivatives of isoflavones amides, as well as a preparation method and medical application of derivatives, in particular to the derivatives of the isoflavones amides with the general formula of (I) shown as the specification, the preparation method and the medical application of the derivatives, particularly the application of the derivatives of the isoflavones amides serving as medicaments for preventing or treating hyperlipemia, adiposis or type-II diabetes.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1643-15-8